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INTRODUCTION  
Extensive before mankind discovered the existence of  
microbes, the idea that certain plants had healing potential, 
indeed, that they contained what we would currently  
characterize as antimicrobial principles was well accepted 
(Kumar et al., 2015, 2016). Since ancient times, man has 
used plants to treat common infectious diseases and some 
of these traditional medicines are still included as part of 
the habitual treatment of various maladies. For example 
species such as lemon balm (Melissa officinalis), garlic 
(Allium sativum) and tea tree (Melaleuca alternifolia) are 
described as broad-spectrum antimicrobial agents (R´ıos 
and Recio, 2005). Natural products perform an assortment 
of functions, and any of them have interesting and useful 
biological activities. There are more than 35,000 plant  
species creature used in various human cultures around the 
world for medicinal purposes (Asolkar et al., 1992; Kumar 
et al., 2015). Researchers are increasingly turning their 
attention to natural products and looking for new leads to 
develop better drugs against cancer, as well as viral and 
microbial infections (Chen et al., 1987; Choe, 1986;  
Kumar et al., 2014, 2015, 2016). Infectious diseases are 
subsequent leading cause of death worldwide. Treatment 
of infections continue to be challenging in modern time 
because of the severe side effects of antimicrobials and the 
growing resistance to these lifesaving drugs due to their 
intensive use (Kumar et al., 2014, 2015; Kilani et al., 
2008). The problem of microbial resistance has become a 
global issue of concern, as about 70 % of the bacteria that 
cause infections in hospitals are resistant to at least one of 
the antibiotic most generally used for treatment (Kirtikar, 
2001; Parekh, 2006; Kumar et al., 2015, 2016). Because of 
this drug resistance, the search for new antibiotics contin-
ues unabated. The increasing malfunction of chemothera-
peutics and antibiotic resistance exhibited by pathogenic 
microbial infectious agents has led to the screening of  
several medicinal plants for their potential antimicrobial 
activity (Sanjay et al., 2010; Kumar et al., 2015). In this 
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ABSTRACT 
In the present study the antibacterial activity was studied against five bacterial pathogens i.e.  
Haemophilus influenzae MTCC 3826, Pseudomonas aeruginosa MTCC 2474, Staphylococcus  
aureus MTCC 1144, Streptococcus pneumoniae MTCC 655 and Streptococcus pyogenes MTCC 
442. Shade dried root were crushed and extracted in petroleum ether (PET), acetone (ACE), metha-
nol (MeOH) and water (H2O) by using Soxhlet apparatus. The agar well diffusion method was 
adopted to examine antibacterial activity of extracts against the susceptible organisms. Erythromy-
cin was used as positive control to determine the sensitivity of the strains. Phytochemical analysis 
was done for plant extract. The results showed that MeOH extract was most active as comparison to 
other extract. The maximum inhibition was found against H. influenzae (18.4±0.07 mm) followed 
by S. pyogenes (17.3±0.13 mm), S. pneumoniae (16.2±0.07 mm) and P. aeruginosa (15.5±0.15 mm) 
respectively. The minimum inhibition was noted against S. aureus (14.4±0.13 mm). The  
phytochemical screening for MeOH extract has shown that plant contains flavonoids, glycosides, 
alkaloids, steroids, terpene, saponins and tannins. Therefore, M. nagi can be helpful as an alternative 
source of medicine and new drug discovery. 
©2017 Agriculture and Environmental Science Academy 
225  
 
relationship plants continue to be a rich source of  
therapeutic drugs. The active principles of many drugs are 
found in plants or are produced as secondary metabolites. 
The remarkable contribution of plants to the drug  
industries was possible, because of the large number of the  
phytochemical and biological studies all above the  
world. The extensive use, mistreatment and overuse of 
antimicrobial in human have gradually more raised levels 
of antimicrobial resistance in wide range of microorgan-
isms globally (WHO, 2013). It is quite difficult to combat 
for new drug resistance with such wide range of resistant 
organisms. Therefore, discovery of new drugs is somewhat  
essential to sort out major clinical and public health prob-
lems grown up by drug resistance. 
The herb Myrica nagi belongs to the plant family Myri-
caceae and the order Fagales. It is also called the Myrica 
esculenta. This herb is commonly referred to by the name 
Kaiphula in Sanskrit and Box Myrtle and Bay Berry in 
English. In Hindi, it is known as the Kafal. The plant Myri-
ca nagi is native to the Hilly regions of the countries Nepal 
and India. It is found extensively in the northern region of 
India, especially in the state of Punjab. It also grows wildly 
in the Garhwal and Kumaon region in Uttarakhand. The 
only part of the tree that has therapeutic value and is used 
for medicinal purposes is its bark. The bark of Kafal con-
tains Myricitrin which kills bacteria and so the bark is used 
for arresting bleeding, removing wind from the stomach, 
arresting secretion, stimulating bile, and for the retention of 
potassium in the body. It is also used as an anti- septic, 
fever, cold, asthma, Intestinal Disorders, teeth disorders, 
wounds and ulcers (Parmar and Kaushal, 1982). The aim 
of this study was to find out antibacterial and phytochemi-
cal aspects of Myrica nagi  root extracts against respiratory 
pathogens that usually cause infections in upper and lower 
respiratory tract region.  
MATERIALS AND METHODS  
Plant material: Plant was collected from Srinagar,  
Uttarakhand and authenticated at Department of Botany 
and Microbiology, H.N.B. Garhwal University, Srinagar. 
Collected roots were dried under shade at room tempera-
ture and crushed to small pieces by using pestle and mortar 
and powdered in an electric grinder.  
Preparation of extract: Plant extracts were prepared by 
immersing 200 g of powdered plant material in 600 ml of 
four different solvents i.e. petroleum ether (PET), acetone 
(ACE), methanol (MeOH) and water (H2O), loaded in 
Soxhlet assembly and extracted for 72 h through succes-
sive method. Plant extracts were filtered through Whatman 
No. 1 filter paper and crude extracts obtained by removing 
solvent in vacuum evaporator at 30°C. Residues were 
stored at 4°C until further use. Extracts were dissolved in 
dimethyl sulfoxide (DMSO) to a final concentration of 200 
mg/ml for agar well diffusion method.  
Test microorganisms: Five bacterial strains causing res-
piratory infections used in this study were Haemophilus 
influenzae MTCC 3826, Pseudomonas aeruginosa MTCC 
2474, Staphylococcus aureus MTCC 1144, Streptococcus 
pneumoniae MTCC 655, Streptococcus pyogenes MTCC 
442. Bacterial strains were procured from Institute of  
Microbial Technology (IMTECH), Chandigarh.  
Preparation of inoculums: Stock cultures were main-
tained at 4°C on slopes of nutrient agar. Active cultures for 
experiments were prepared by transferring a loopful of 
cells from stock cultures to test tubes of Mueller-Hinton 
broth (MHB) for bacteria that were incubated without  
agitation for 24 h at 37°C.  
Antibacterial testing: The antibacterial activity of differ-
ent extracts was determined by agar well-diffusion method 
(Ahmed et al., 1998). 0.1 ml of 12-16 h incubated cultures 
of bacterial species were mixed in molten Mueller Hinton 
Agar medium no. 173 (Hi Media Pvt. Ltd., Mumbai, India) 
and poured in pre-sterilized petri plates. A cork borer (6 
mm diameter) used to punch wells in solidified medium 
and filled with extracts of 45 μl of 200 mg/ml final concen-
tration of extracts. DMSO was used as negative control. 
The efficacy of extracts against bacteria was compared 
with the broad spectrum antibiotic erythromycin (positive 
control). The plates were incubated at 37°C for 24 h in 
BOD incubator and the diameter of the zone of inhibition 
was measured in millimetre. Each sample was assayed in 
triplicate and the mean values were observed. The antibac-
terial activity was interpreted from the size of the diameter 
of zone of inhibition measured to the nearest millimetre 
(mm) as observed from the clear zones surrounding the 
wells.  
Phytochemical screening: Major phyto-constituents  
present in Myrica nagi extracts were subjected to phyto-
chemical analysis to determine the presence of bioactive 
components by using standard qualitative methods (Trease 
and Evans, 1996; Evans, 2009).  
Test for alkaloids: Test solution was acidified with acetic 
acid and a drop of Mayer’s reagent was added. A white 
precipitate indicated the presence of alkaloids.  
Test for flavonoids: On addition of conc. HCl in meth-
anolic extract of material, a red colour appeared which 
indicated the presence of flavonoids.  
Test for glycosides: Plant extract was filtered and sugar 
was removed by fermentation with baker’s yeast. The acid 
was removed by precipitation with Ba(OH)2. The remain-
ing extract contained the glycosides. The hydrolysis of 
solution was done with conc. H2SO4 and after hydrolysis 
the presence of sugars was determined with help of Feh-
ling’s solution.  
Test for steroids: The extract mixed with 3 ml CHCl3 and 
2 ml conc. H2SO4 was poured from side of test tube and 
colour of the ring at junction of two layers was noted. A 
red colour showed the presence of steroids.  
Test for saponins: Extracts were diluted with distilled 
water to 20 ml and this was shaken in a graduated cylinder 
for 15 minutes. Formation of 1 cm layer of foam indicates 
the presence of saponins.  
Test for tannins: Extract was added in 1% ferric chloride 
and observed the colour. Bluish black colour appeared 
which disappeared on addition of dilute H2SO4 follow a 
yellow brown precipitate indicates the presence of tannins.  
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RESULTS AND DISCUSSION  
The results for antibacterial activity are depicted in Table 1 
and Figure 1. MeOH extract was found most active against 
all test pathogens in comparison to other extracts. The 
maximum inhibition was found against H. influenzae 
(18.4±0.07 mm) followed by S. pyogenes (17.3±0.13 mm), 
S. pneumoniae (16.2±0.07 mm) and P. aeruginosa 
(15.5±0.15 mm) respectively. The minimum inhibition was 
noted against S. aureus (14.4±0.13 mm). M. nagi crude ex-
tracts was found less active in comparison to positive control 
(erythromycin). The inhibition zone diameters of various 
extracts of M. nagi root.  
The decoction of ethanolic extract of the bark of Myrica 
nagi showed antibacterial activity was performed on five 
different species of bacteria that includes three gram positive 
bacteria (Bacillus cereus, Listeria monocytogenes, S. aure-
us) and two gram negative bacteria (Escherichia coli, and  
Almonella anatum)  as also reported by Shan et al. (2007). 
Chandra et al. (2012) has also been reported to assess the 
anti-bacterial and anti-fungal activity of Myrica nagi fruit 
pulp difference extracts (Pt. ether, chloroform, ethyl  
acetate, acetone, ethanol and water extract) active against 
Ten bacterial strains (Escherichia coli, Klebsiella pneu-
moniae, Enterobacter gergoviae, Salmonella enter-
icatyphim, Shigella flexneri, Staphyloccus aureus,  
Staphyloccus  pidermidis, Streptococcus pyogenes and  
Bacillus cereus) and three fungal (Candida albicans,  
Aspergillus flavus and Aspergillus parasiticus) by using disc 
diffusion method. The Myrica esculenta bark of  
aqueous ethanolic extract active against adult Indian  
earthworm Pheritima posthuma and more potent than refer-
ence control piperazine citrate (Jan, 2010; Vaghasiya, 2009). 
The phytochemical screening of M. nagi extract has shown 
that plant contains alkaloids, flavonoids, glycosides,  
Steroids, Saponins and Tannins which are very important 
constituents when looking for pharmacologically active 
phytochemical in the plant (Table 2). Chandra et al. (2012) 
had reported a variety of constituents i.e. alkaloids, flavo-
noids, glycosides, steroids, proteins, phenolics and  
Tannins present in M. nagi. Moreover, M. nagi is also used 
as traditional veterinary medicine in India; it is used as an 
ingredient of an ointment against sprains and sores 
(Mazars, 1994). By this study, it is concluded that M. nagi 
can be used as herbal medicine to treat respiratory infec-
tions caused by tested pathogens as compared to  
synthetic chemotherapeutic agents. It is urged that further 
research should be brought out to expose the bioactive 
constituents present in M. nagi.  
Table 1. The percentage of potency of M. nagi extracts against respiratory tract pathogens. 
S.N. Pathogens 
Diameters of inhibition zone (mm) 
PET CHCl3 MeOH H2O 
1. H. influenza 12.3±0.12 14.3±0.1 17.3±0.1 9.2±0.05 
2. H. influenzae (MTCC 3826) 11.2±0.1 13.7±0.07 18.4±0.07 10.4±0.16 
3. P. aeruginosa 9.5±0.07 10.2±0.1 15.5±0.15 11.2±0.07 
4. P. aeruginosa (MTCC 2474) 10.4±0.07 11.4±0.05 15.1±0.07 10.3±0.07 
5. S. aureus 9.4±0.12 11.3±0.07 15.3±0.05 9.2±0.1 
6. S. aureus (MTCC 1144) 10±0.15 10.4±0.07 14.4±0.13 11.1±0.05 
7. S. pneumonia 10.1±0.13 9.5±0.1 16.2±0.07 12.5±0.1 
8. S. pneumoniae (MTCC 655) 9.4±0.07 10.7±0.07 15.1±0.08 11.3±0.07 
9. S. pyogenes 10.3±0.07 11.7±0.05 17.3±0.13 12.3±0.05 
10. S. pyogenes (MTCC 442) 10.4±0.11 10.7±0.05 16.1±0.03 13.1±0.02 
*Values are means of three replicates, Cork borer diameter: 6 mm. 
Table 2. The phytochemical screening of crude extracts of M. nagi.   
S.N. Phytoconstituents 
Solvents 
PET ACE MeOH H2O 
1. Alkaloids - + + + 
2. Flavonoids - + + + 
3. Glycosides - + - + 
4. Steroids + + + + 
5. Saponins - - + + 
6. Tannins + + + + 
+ = Present, - = Absent. 
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Conclusions 
The investigation for antibacterial activity of M. nagi root 
extracts revealed that plant has broad spectrum activity 
against selected bacteria which explain the basis for its use 
in traditional medicines. The significant activity was exhib-
ited by MeOH extract against test respiratory pathogenic 
microorganisms. The study supported the usefulness in 
term of availability of phytoconstituents. By results, it can 
be concluded that M. nagi can be helpful as an alternative 
source of medicine and new drug discovery. 
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Figure 1. Inhibition zone of M. 
nagi extracts at 200 mg/ml concen-
tration 1) PET 2) CHCl3 3) MeOH 
4) H2O against respiratory tract 
pathogens (A) Streptococcus pneu-
moniae MTCC 655 (B) Staphylo-
coccus aureus MTCC 1144  (C) 
Streptococcus pyogenes 442 (D)
Pseudomonas aeruginosa MTCC 
2474 (E) Haemophilus influenzae 
MTCC 3826. 
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